
ProShares Ultra Nasdaq Biotechnology (BIB) Price & Chart
BIB ETF Chart & Stats
- Day’s Range
- $112.00 - $118.03
- 52-Week Range
- $67.50 - $126.40
- Previous Close
- $112.66
- Volume
- 5,876
- Average Volume (3M)
- 9,991
- AUM
- 99.29M
- NAV
- 117.75
- Expense Ratio
- 0.95%
- Holdings Count
- 245
- Beta
- 1.50
- Inception Date
- Apr 07, 2010
- Last Dividend Ex-Date
- Sep 23, 2026
- Dividend Yield
- (0.19%)
- Shares Outstanding
- 870,000
- Standard Deviation
- N/A
ETF Overview
ProShares Ultra Nasdaq Biotechnology
ProShares Ultra Nasdaq Biotechnology (BIB) is an Exchange Traded Fund (ETF) that provides investors with amplified exposure to the dynamic health care sector, specifically focusing on the cutting-edge fields of pharmaceuticals, biotechnology, and life sciences. This ETF is designed for those looking to capitalize on the rapid advancements and innovation within the biotech industry, offering a leveraged approach that seeks to deliver twice the daily performance of the Nasdaq Biotechnology Index. By investing in BIB, individuals gain access to a diversified portfolio of pioneering companies at the forefront of developing revolutionary treatments and technologies, positioning themselves to potentially benefit from the sector's growth and breakthroughs. Ideal for investors with a high-risk tolerance seeking substantial short-term gains, BIB is a powerful tool for those looking to harness the transformative potential of the biotechnology landscape.
- Asset Class
- Equity
- Region
- North America
- Issuer
- ProShares
- Index Tracked
- NASDAQ / Biotechnology
- Ticker Symbol
- BIB
BIB ETF News




Regeneron Pharmaceuticals ($REGN) announced an update on their ongoing clinical study. Study Overview: Regeneron’s official title is “A Randomized, Open-Label, C5 Inhibitor-Controlled Study to Evaluate the Efficacy and Safety of









